Structural and mechanistic insights into ras association domains of phospholipase C epsilon

被引:118
作者
Bunney, TD
Harris, R
Gandarillas, NL
Josephs, MB
Roe, SM
Sorli, SC
Paterson, HF
Rodrigues-Lima, F
Esposito, D
Ponting, CP
Gierschik, P
Pearl, LH
Driscoll, PC
Katan, M
机构
[1] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England
[2] Inst Canc Res, Struct Biol Chester Beatty Labs, London SW3 6JB, England
[3] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
[4] Univ Paris 07, UFR Biochim, F-75005 Paris, France
[5] Univ Paris 07, Lab Ctyophysiol & Toxicol Cellulaire, F-75005 Paris, France
[6] Natl Inst Med Res, London NW7 1AA, England
[7] Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3QX, England
[8] Univ Ulm, Dept Pharmacol & Toxicol, D-89069 Ulm, Germany
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.molcel.2006.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras proteins signal to a number of distinct pathways by interacting with diverse effectors. Studies of ras/effect or interactions have focused on three classes, Raf kinases, ral guanylnucleotide-exchange factors, and phosphatidylinositol-3-kinases. Here we describe ras interactions with another effector, the recently identified phospholipase C epsilon (PLC epsilon). We solved structures of PLC epsilon RA domains (RA1 and RA2) by NMR and the structure of the RA2/ras complex by X-ray crystallography. Although the similarity between ubiqultin-like folds of RA1 and RA2 proves that they are homologs, only RA2 can bind ras. Some of the features of the RA2/ras interface are unique to PLC epsilon, while the ability to make contacts with both switch I and II regions of ras is shared only with phosphatidylinositol-3-kinase. Studies of PLC epsilon regulation suggest that, in a cellular context, the RA2 domain, in a mode specific to PLC epsilon, has a role in membrane targeting with further regulatory impact on PLC activity.
引用
收藏
页码:495 / 507
页数:13
相关论文
共 29 条
  • [1] Crucial role of phospholipase CE in chemical carcinogen-induced skin tumor development
    Bai, YF
    Edamatsu, H
    Maeda, S
    Saito, H
    Suzuki, N
    Satoh, T
    Kataoka, T
    [J]. CANCER RESEARCH, 2004, 64 (24) : 8808 - 8810
  • [2] Oncogenic Ras and its role in tumor cell invasion and metastasis
    Campbell, PM
    Der, CJ
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (02) : 105 - 114
  • [3] Targeting ras signalling pathways in cancer therapy
    Downward, J
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 11 - 22
  • [4] RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity
    Frankel, P
    Aronheim, A
    Kavanagh, E
    Balda, MS
    Matter, K
    Bunney, TD
    Marshall, CJ
    [J]. EMBO JOURNAL, 2005, 24 (01) : 54 - 62
  • [5] Ras-effector interactions: after one decade
    Herrmann, C
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2003, 13 (01) : 122 - 129
  • [6] Differential interaction of the Ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor
    Herrmann, C
    Horn, G
    Spaargaren, M
    Wittinghofer, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) : 6794 - 6800
  • [7] Illenberger D, 2000, METHOD ENZYMOL, V325, P167
  • [8] Hormonal regulation of phospholipase Cε through distinct and overlapping pathways involving G12 and Ras family G-proteins
    Kelley, GG
    Reks, SE
    Smrcka, AV
    [J]. BIOCHEMICAL JOURNAL, 2004, 378 : 129 - 139
  • [9] Phospholipase Cε:: a novel Ras effector
    Kelley, GG
    Reks, SE
    Ondrako, JM
    Smrcka, AV
    [J]. EMBO JOURNAL, 2001, 20 (04) : 743 - 754
  • [10] The activation of RalGDS can be achieved independently of its Ras binding domain - Implications of an activation mechanism in Ras effector specificity and signal distribution
    Linnemann, T
    Kiel, C
    Herter, P
    Herrmann, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 7831 - 7837